Jun 30, 2026
14 MIN READ

Ozempic Results After One Year: What Long-Term Use Looks Like

One year of semaglutide therapy often produces sustained weight loss and metabolic improvements that extend far beyond the first month. Discover what research shows about maintaining results over 12 months.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 30, 2026
14 MIN READ

ozempic results after one year: what long-term use looks like — PlexusDx GLP-1 education

Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

After 12 months of consistent semaglutide use, patients typically experience cumulative metabolic shifts that go deeper than initial weight loss numbers suggest. Research from the STEP trials demonstrates that people using GLP-1 therapy maintain meaningful results throughout the year, with many experiencing continued improvements in blood sugar regulation, appetite control, and cardiovascular markers alongside weight reduction.

Average Weight Loss After 12 Months of Semaglutide

Clinical data shows that people following a consistent semaglutide regimen for one full year typically achieve cumulative weight reductions between 15% and 22% of their starting body weight. This translates to roughly 30 to 50 pounds for someone beginning treatment at 200 pounds, though individual results depend on baseline weight, dose progression, and lifestyle factors. The majority of this loss concentrates in the first six months, but the second half of the year often brings stabilization rather than weight regain—a critical distinction from many traditional diet approaches.

Month-to-month progression rarely follows a straight line downward. Most patients experience rapid initial drops during weeks 4-12, then a gradual plateau around month 4-5, followed by continued slower losses through month 12. This pattern reflects the body adjusting to the medication while sustained appetite suppression and improved satiety signals keep overall calorie intake lower without requiring restrictive willpower.

How Metabolic Health Improves Beyond the Scale

Weight loss is only one marker of semaglutide's one-year impact. Data consistently shows improvements in fasting blood glucose, insulin levels, and hemoglobin A1C that often exceed what weight loss alone would predict. People with prediabetes or type 2 diabetes frequently move into better metabolic categories within 6-9 months, with some reversing prediabetic A1C levels entirely. These changes reflect semaglutide's direct effects on pancreatic beta cells and insulin sensitivity, not just reduced calorie intake.

Cardiovascular risk markers also shift meaningfully over 12 months. Blood pressure often decreases by 5-10 mmHg, triglycerides drop in many patients, and inflammation markers like C-reactive protein improve. These metabolic wins remain even if someone's weight plateaus, meaning the health benefit continues accumulating throughout the year independently of the scale.

What Happens to Appetite and Food Preferences During Year One

By the 12-month mark, many patients report that appetite suppression becomes their baseline rather than a side effect. The constant, moderate reduction in hunger signals that feels intense during month two gradually becomes normalized, allowing people to eat smaller portions without feeling deprived. Simultaneously, food preferences often shift—high-fat, high-sugar options that triggered cravings before therapy feel less appealing, while protein-rich and whole-food choices become more satisfying with smaller quantities.

Sustained appetite control is semaglutide's longest-lasting benefit because the medication continues working the same way throughout the year. The GLP-1 receptor remains engaged, gastric emptying stays modulated, and satiety signals persist. This consistency means that year-one results don't depend on willpower erosion or mounting cravings—the biological support remains constant, making weight maintenance easier than it would be after restrictive dieting alone.

Long-Term Sustainability and What Changes After Month 12

Research on extended semaglutide use beyond one year shows that weight stabilization is the norm when people continue their medication and lifestyle practices. Weight regain happens rapidly after stopping semaglutide because appetite signals and metabolic rate return to baseline within weeks, but patients who remain on therapy maintain their gains. This reality makes semaglutide more accurately described as a chronic disease management tool rather than a short-term intervention, similar to how blood pressure or diabetes medications work long-term.

PlexusDx supports sustained results through personalized dosing and optional genetic insights via the Precision Peptide Genetic Test, which identifies individual variations in GLP-1 receptor pathways (like GLP1R rs6923761) and other metabolic genes (MC4R rs17782313, FTO rs9939609) that predict individual response patterns. This testing helps optimize therapy beyond the standard protocol, enabling some patients to achieve better year-one outcomes and informed decisions about long-term continuation.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I realistically lose in one year on semaglutide?

Clinical trials show average weight loss between 15-22% of starting body weight over 12 months, with most loss occurring in the first six months. Individual results vary based on starting weight, dose escalation, and adherence to medication plus lifestyle changes like increased protein and movement.

Will my blood sugar improve if I'm prediabetic after one year of semaglutide?

Yes—research consistently demonstrates improvements in fasting glucose and A1C levels within 6-9 months, often moving prediabetic patients into normal ranges. These benefits reflect semaglutide's direct effects on pancreatic insulin secretion and glucose handling, not just weight loss.

What does semaglutide cost at PlexusDx, and is there a flat per-compound pricing increase?

PlexusDx Compounded Semaglutide Injection starts at $149/month across all dose levels—your dose may need to go up, but your price won't. PlexusDx serves all 50 states with no insurance required, no membership fee, and HSA/FSA eligibility for cost savings.

What happens to my weight if I stop semaglutide after one year?

Weight regain typically begins within weeks of stopping because appetite signals and metabolic rate return to baseline. Most people regain 50% or more of lost weight within 1-2 years post-discontinuation, which is why semaglutide works best as a sustained therapy rather than a short-term program.

Can genetic testing help predict if I'll get good results on semaglutide?

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after first month), which maps variants in GLP1R, GIPR, FTO, and MC4R genes linked to individual response patterns. This personalized insight helps optimize dosing strategy and predict likelihood of sustained success over 12 months and beyond.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves